Literature DB >> 15890243

Polymorphism in the genes of alpha and beta tumor necrosis factors (TNF-alpha and TNF-beta) and gamma interferon (IFN-gamma) among Iranian women with breast cancer.

Eskandar Kamali-Sarvestani1, Ahmad Merat, Abdol-Rasoul Talei.   

Abstract

The association of the polymorphism in the genes of TNF-alpha, TNF-beta and IFN-gamma with breast cancer was investigated in the present study. There were no differences in the TNF-alpha and TNF-beta alleles and genotypes frequencies between breast cancer patients (n=223) and control subjects (n=267). The correlations between TNFA or TNFB alleles or genotypes and clinicopathological indices were also insignificant. However, the frequency of IFN-gamma+874 T/T genotype was significantly higher in breast cancer patients compared to those of controls (P<0.002; OR=2.03, 95% CI=1.28-3.2) which indicates that Iranian women carrying the IFN-gamma+874 T/T genotype may be exposed to an increased risk of breast cancer development.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890243     DOI: 10.1016/j.canlet.2004.09.025

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  20 in total

1.  Association between the TNF-α-238G>A and TGF-β1 L10P Polymorphisms and Breast Cancer Risk: A Meta-Analysis.

Authors:  Jun Guo; Hua Meng; Jianming Pei; Miaozhang Zhu
Journal:  Breast Care (Basel)       Date:  2011-04-29       Impact factor: 2.860

2.  The Impact of IFN-γ Gene Polymorphisms on Spontaneous Clearance of HCV Infection in Fars Province, Southern of Iran.

Authors:  Jamal Sarvari; Afagh Moattari; Neda Pirbonyeh; Maryam Moini; Seyed Younes Hosseini
Journal:  J Clin Lab Anal       Date:  2015-05-20       Impact factor: 2.352

3.  Correlations of IFN-γ genetic polymorphisms with susceptibility to breast cancer: a meta-analysis.

Authors:  Chun-Jiang Li; Yue Dai; Yan-Jun Fu; Jia-Ming Tian; Jin-Lun Li; Hong-Jun Lu; Feng Duan; Qing-Wang Li
Journal:  Tumour Biol       Date:  2014-04-16

4.  Association between the IFN-γ and IL-1 genetic polymorphisms and colorectal cancer in the Chinese Han population.

Authors:  Bao-Ying Fei; Huo-Xiang Lv; Yong-Wei Cheng; Jiang-Ming Yang
Journal:  J Genet       Date:  2014-04       Impact factor: 1.166

5.  Association of TNF-α Promoter Polymorphism with HBV Associated Disease Outcome Among HBV Infected Patients from Orissa, Southern Part of East India.

Authors:  Rajesh Panigrahi; Neelakshi Sarkar; Avik Biswas; Ananya Pal; Debraj Saha; Shivaram P Singh; Manas K Panigrahi; Manikanana Bandopadhyay; Sekhar Chakrabarti; Runu Chakravarty
Journal:  J Clin Exp Hepatol       Date:  2014-09-18

6.  Interferon gamma +874 T/A polymorphism contributes to cancer susceptibility: a meta-analysis based on 17 case-control studies.

Authors:  Yuan-Yuan Mi; Qian-Qian Yu; Bin Xu; Li-Feng Zhang; Zhi-Chao Min; Li-Xin Hua; Ning-Han Feng; Yong Yao
Journal:  Mol Biol Rep       Date:  2010-12-03       Impact factor: 2.316

7.  Lack of association between interferon gamma +874 T/A polymorphism and cancer risk: an updated meta-analysis.

Authors:  Yu-Zheng Ge; Yi-Dan Wang; Zheng Xu; Lu-Wei Xu; Ya-Ping Wang; Mao-Hong Gu; Ai-Xing Ding; Xian-Bo Zhu; Ran Wu; Wen-Cheng Li; You-Di Xu; Rui-Peng Jia
Journal:  Tumour Biol       Date:  2014-03-28

8.  Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection.

Authors:  Meiqiang Liu; Bangwei Cao; Hongkun Zhang; Yue Dai; Xiaolin Liu; Changqing Xu
Journal:  Immunogenetics       Date:  2006-10-11       Impact factor: 2.846

9.  TNF-β +252 A>G polymorphism and susceptibility to cancer.

Authors:  Lin Yang; Rennan Feng; Guiyou Liu; Mingzhi Liao; Liangcai Zhang; Wenbo Wang
Journal:  J Cancer Res Clin Oncol       Date:  2013-02-03       Impact factor: 4.553

10.  IFN-γ (+874) and not TNF-α (-308) is associated with HBV-HCC risk in India.

Authors:  Roli Saxena; Yogesh Kumar Chawla; Indu Verma; Jyotdeep Kaur
Journal:  Mol Cell Biochem       Date:  2013-10-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.